The United States Preventive Services Task Force (USPSTF) recommends a PSA cut-off threshold of 4 ng/mL for PC screening and a follow-up prostate biopsy when PSA levels > 4.0 ng/mL are detected [7]. This evidence concerns the gene KLK3 and pachyonychia congenita.